Molecular Diagnostics
Early Warning Biomarker Proteins Appear Years or Decades Before Alzheimer’s Disease Symptoms
A large proteomic study linked abnormal blood levels of 38 proteins to higher risks of developing Alzheimer's disease within five years and showed that levels of 16 of these proteins could predict Alzheimer's disease risk two decades in advance. More...26 May 2021
Non‐Invasive Urine Markers Differentiate Renal Cancer from Oncocytoma
Clear cell renal cell carcinoma, (ccRCC), is a type of kidney cancer. Clear cell renal cell carcinoma is also called conventional renal cell carcinoma. Clear cell renal cell carcinoma is named after how the tumor looks under the microscope. More...25 May 2021
Jagged Ends of Urinary Cell-Free DNA Assessed in Bladder Cancer Detection
Bladder cancer is where a growth of abnormal tissue, known as a tumor, develops in the bladder lining. In some cases, the tumor spreads into the bladder muscle. The most common symptom of bladder cancer is blood in the urine, which is usually painless. More...24 May 2021
Loss of Function Mutations in GEMIN5 Causes Neurodevelopmental Disorder
GEMIN5, an RNA-binding protein is essential for assembly of the survival motor neuron (SMN) protein complex and facilitates the formation of small nuclear ribonucleoproteins (snRNPs), the building blocks of spliceosomes. More...20 May 2021
Elevated Cytokine Levels Linked to Future Development of Myocardial Infarction
Elevated levels of the plasma biomarkers interleukin-6 (IL-6) and the IL-6 binary complex have been linked to the increased risk of myocardial infarction (MI) found in smokers and individuals with hypertension. More...17 May 2021
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
ESR Analyzer
TEST1 2.0
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
In Other News
New Blood Test Promises Biopsy-Free Colon Cancer Diagnosis
A Novel Capsule-Based Smell Test for Diagnosis of Neurological and Respiratory Diseases
Genetic Background and Clinicopathologic Features Established for Adult-Onset Nephronophthisis
LAMP Assay Developed to Diagnose High HBV DNA Levels
Protein Biomarker Increases Sensitivity of a Urine-based Prostate Cancer Test
Blood-based Liquid Biopsy Detects Lymph Node Metastasis in Colorectal Cancer Patients
GPS Assay Associated with Long-Term Prostate Cancer Outcomes
A Rapid Metabolomic Test for Early Diagnosis of Myocardial Infarction
Genetic Factors Linked to Severe COVID-19, Viral Infections in Children
New Genetic Factors Involved in Sudden Unexpected Death in Children
Novel Urine-based Liquid Biopsy for Early Detection of Aggressive Prostate Cancer
Serum Amyloid A Levels Linked to Likelihood of Developing Severe COVID-19
Different Methods Compared for Isolating Fungal DNA
Digital PCR Improves BCR-ABL1 Detection in Chronic Myeloid Leukemia
RNA-Sequencing Predicts Immunotherapy Success in Bladder Cancer
An Ultrasensitive Assay for Measurement of Levels of Cathepsin B in the Blood
A Method for Accurately Assessing the Latent Virus Reservoir in Chronic HIV Patients
Sensitive PCR Test Detects Early Stage Lyme Disease
Randox Discovery Diagnostic Analyzer Wins 2021 Red Dot Award for High Design Quality
T Cells Recognize Recent SARS-CoV-2 Variants
Novel Lipid Biomarker Detects Senescent Cells
Leukocyte Epigenomics and Artificial Intelligence Predict Late-Onset Alzheimer’s Disease
A Protein Biomarker Aids Cancer Patients by Controlling the Dosage of Highly Toxic Cisplatin
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.